Troutman Pepper

Combining strong overarching life sciences knowledge with compelling litigation sensibilities, Troutman Pepper is a popular choice among leading drug manufacturers and medical device companies, including Eli Lilly, GSK and Becton Dickinson, in the defense of high-stakes product liability, mass tort, and personal injury claims across a wide range of products. Through proactive strategies at a motions stage in large mass tort/MDL proceedings the team, which has particularly strength from Philadelphia and Atlanta, has paved the way for future victories, for example, through  successfully excluding or limiting plaintiff expert testimony. Similarly, it is unafraid to try cases and has built an excellent track record of successfully representing clients in traditionally plaintiff-friendly jurisdictions. Philadelphia-based Barry Boise combines strong trial experience, including as it relates to government investigations, with counselling and regulatory prowess to provide comprehensive protection for many leading clients. In Atlanta, Eric Rumanek combines science and legal knowledge to good effect, helping smaller pharmaceutical companies to avoid litigation and to comply with oftentimes burdensome regulatory strictures, as well as acting as national and trial counsel for higher-profile companies in large scale mass torts. Leveraging his impressive trial skills, Philadelphia-based team head Sean Fahey regularly gains impressive concessions on settlements, as well as often acting as first-chair in high-profile trials involving complex technical and scientific issues.